Longevity Leaders Logo White

RNA_Leaders_Logo_White



SCIENTIFIC, CLINICAL AND COMMERCIAL DEVELOPMENT OF RNA THERAPEUTICS AND VACCINES


16-17 March 2022
Congress Center Basel, Switzerland
Virtual Attendance Option


#rnaleaders
@lsxleaders

DOWNLOAD BROCHURE

Created by    LSX

A new paradigm for disease prevention



RNA medicines are at a critical moment in time. mRNA vaccines dominate the headlines in the wake of the COVID-19 pandemic. But huge advances are also being made in RNAi and antisense technologies. Our understanding of RNA chemistry continues to mature. Delivery tools are increasingly sophisticated and impactful. Advances in genomics and gene editing are driving new approaches. And exciting work targeting RNA with small molecules is emerging.

With that in mind, we can’t wait to bring the community together, face-to-face, for the first annual RNA Leaders World Congress.

So, if you’re passionate about all things RNA do join us, and more than 150 biotech, pharmaceutical, investment, regulatory and scientific professionals at the RNA Leaders World Congress. You’ll hear the latest advances in RNA chemistry, get clinical updates from the companies developing new therapies and source the services partners who are helping to deliver drugs to patients.

RNA Leaders World Congress

“We still have work to do, but the future is bright for RNA therapies.”
Lorna Harries, CSO, Senisca

What will you learn?



  • How the RNA field has accelerated in the past two years, including major scientific and clinical developments
  • New advancements in systemic and topical delivery platforms and their applications
  • How computational biology is advancing RNA drug discovery including new tools for target, mechanism and molecule discovery
  • Latest pre-clinical updates spanning mRNA, RNAi, antisense and targeting RNA with small molecules
  • Application of gene therapy and RNA editing approaches

DOWNLOAD BROCHURE

500+ companies actively developing RNA therapeutics

4000+ live clinical trials for RNA therapeutics and vaccines

2 major mRNA vaccine approvals in 2020

3 RNAi therapeutic approvals in the past 4 years

1500+ investors actively looking to fund RNA technology

96 successful fund raises by mid 2021 (vs 101 total in 2020)

More than $1.65bn raised by RNA biotech mid 2021

Millions of lives saved by mRNA vaccines to date

Become a partner



Do you offer products or services to support RNA drug development? The pharma and biotech executives attending RNA Leaders World Congress want to meet you! They are looking for:

  • Delivery platforms
  • Contract research
  • Equipment supply
  • Target discovery tools
  • CDMO and CMC
  • Reagent providers
  • RNA editing tools
  • RNA analysis
  • Legal services

SPONSORSHIP PROSPECTUS

Female Founders

Networking, Dialogue And Mentorship For Women In Health And Life Sciences
Members save 25% off all LSX events.

FIND OUT MORE

Subscribe to hear speaker announcements, ticket offers and more